AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Tardive dyskinesia is a common side effect associated with long-term use of typical antipsychotic agents. The risk is usually lower with the use of atypical antipsychotic agents. Aripiprazole (Abilify) is a third generation antipsychotic with a unique pharmacological profile of being a partial D2 receptor agonist, and regarded as a relatively safe antipsychotic agent with regard to risk of precipitating tardive dyskinesia. The following case reported an elderly man developing tardive dyskinesia after receiving aripiprazole. (1)
A 62-year-old man with post-traumatic stress disorder was evaluated for a progressive history of involuntary movements affecting …